Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Zimmer Biomet Q1 2026 Earnings Call - Strong Tech Momentum Amidst U.S. Sales Force Transformation
Zimmer Biomet delivered a robust start to 2026, characterized by double-digit technology sales growth and an adjusted EPS beat of $2.09. While the company navigates a complex transition in its U.S. go...
- Organic constant currency sales grew 2.9% in Q1, hitting the upper end of the annual guidance range.
- Adjusted EPS rose 15% year-over-year to $2.09, bolstered by a $0.20 benefit from tariff-related items.
- Technology sales experienced strong double-digit growth, driven by ROSA and TMINI systems.
- +9 more takeaways
PJT Partners Q1 2026 Earnings Call - Record Revenues Driven by Strategic Advisory and Restructuring Demand
PJT Partners delivered a powerhouse first quarter, posting record revenues of $418 million, a 29% increase year-over-year. The firm is effectively playing both sides of the market: while Strategic Adv...
- Total revenues hit a record $418 million, representing 29% year-over-year growth.
- Adjusted pre-tax income surged 49% to $84 million, with margins expanding to 20.1%.
- Strategic Advisory saw significant revenue growth, supported by a 15% increase in mandate counts.
- +9 more takeaways
UPS Q1 2026 Earnings Call - Executing the Amazon Glide Down and Pivot to Premium
UPS is mid-transformation, and the first quarter of 2026 reflects the friction inherent in such a massive pivot. The company is aggressively shedding low-margin volume, most notably through its 'Amazo...
- UPS is nearing the end of its strategic 'Amazon glide down,' with Amazon volume now representing only 8.8% of total revenue, down from over 13%.
- The company is aggressively pursuing a $3 billion cost-savings target for 2026 through network reconfiguration and automation.
- A voluntary driver buyout program, 'Driver Choice,' was oversubscribed, successfully reducing full-time driver positions by approximately 7,500.
- +9 more takeaways
Herc Holdings Q1 2026 Earnings Call - Integration Complete as Focus Shifts to Back-Half Growth
Herc Holdings has officially turned the page on its massive H&E Equipment Services acquisition, moving from a period of intense integration to one of aggressive execution. While first-quarter results ...
- The integration of H&E Equipment Services, the largest acquisition in the industry, is now officially complete.
- Herc's branch network has expanded by 30% following the merger.
- Management expects a significant inflection point in Q2, with revenue and margin expansion expected to drive the second half of 2026.
- +8 more takeaways
Purple Innovation Q1 2026 Earnings Call - Accounting Adjustments and Premium Product Pivot
Purple Innovation's first quarter was a study in structural transition. While top-line revenue fell 8% year-over-year, much of the headline volatility stems from a $4.9 million accounting reclassifica...
- Total net revenue declined 8.1% year-over-year, though this includes a $4.9 million accounting-related reduction in wholesale revenue.
- Excluding the accounting impact, net revenue would have been $100.6 million, representing only a 3.4% decline.
- Showroom performance remains the primary bright spot, with sales up 5% and comparable sales increasing by 7%.
- +8 more takeaways
Omnicell Q1 2026 Earnings Call - Transition to Titan XT and OmniSphere Drives Margin Expansion
Omnicell opened 2026 with a performance that suggests the company is successfully navigating a critical technological pivot. By beating top-end guidance across key metrics, management signaled that th...
- Total revenue for Q1 2026 reached $310 million, marking a 15% year-over-year increase.
- Non-GAAP EBITDA rose significantly to $45 million from $24 million in the prior year period.
- Non-GAAP EPS was $0.55, a substantial improvement over the $0.26 reported in Q1 2025.
- +8 more takeaways
Novartis Q1 2026 Earnings Call - Priority Brands Drive Growth Amidst Generic Erosion
Novartis opened 2026 with a tale of two halves. On one side, the company's priority brands and new launches are firing on all cylinders, posting a combined 34% growth in constant currency. Kisqali, Pl...
- Priority brands and new launches delivered 34% growth in constant currency during Q1.
- Kisqali saw 55% growth, bolstered by strong market share in early breast cancer (65%+ NBRX in the U.S.).
- Pluvicto sales grew 76% in the U.S., driven largely by the pre-taxane mCRPC setting.
- +9 more takeaways
Kiniksa Q1 2026 Earnings Call - ARCALYST Revenue Surges as Pipeline Milestones Loom
Kiniksa delivered a powerhouse first quarter, driven by the relentless commercial momentum of ARCALYST. Net revenue for the franchise hit $214.3 million, a 56% year-over-year jump that effectively shr...
- ARCALYST net revenue reached $214.3 million in Q1 2026, a 56% increase year-over-year.
- Kiniksa raised its full-year 2026 revenue guidance to $930 million–$945 million from the previous $900 million–$920 million range.
- New prescriber growth hit a post-launch high, with approximately 400 new prescribers added in Q1 alone.
- +8 more takeaways
Brown & Brown Q1 2025 Earnings Call - Specialty Distribution and AI Integration Drive Resilient Margins Amid Property Rate Volatility
Brown & Brown delivered a robust first quarter, characterized by massive top-line growth of 35.4% fueled largely by the Accession acquisition. While organic revenue growth remained relatively flat due...
- Total revenues surged 35.4% year-over-year to $1.9 billion, largely driven by the integration of Accession.
- Adjusted EBITDAC margins expanded by 40 basis points to 38.5%, showcasing strong expense discipline and margin protection.
- Contingent commissions grew by an impressive $54 million, providing a critical buffer against organic growth pressures.
- +7 more takeaways
Hillman Solutions Q1 2026 Earnings Call - Navigating Tariff Headwinds and Pro Channel Expansion
Hillman Solutions delivered a mixed first quarter, characterized by a 3% increase in net sales but an 8% drop in Adjusted EBITDA. The company faced a perfect storm of seasonal softness in January and ...
- Net sales for Q1 2026 grew 3% year-over-year to $370.1 million, despite a slow start in January and February.
- Adjusted EBITDA fell 8% to $50.1 million, pressured by high-cost tariff inventory and soft volume in specific segments.
- Management raised full-year net sales guidance to a midpoint of $1.68 billion, an 8% increase over last year.
- +8 more takeaways